Novel Associations of Empagliflozin on the Gut Microbiome and Metabolome in Type 2 Diabetes

Journal Article Novel Associations of Empagliflozin on the Gut Microbiome and Metabolome in Type 2 Diabetes Get access Ashani Lecamwasam, Ashani Lecamwasam Department of Endocrinology, Austin Health, Victoria, AustraliaDepartment of Medicine, University of Melbourne, Victoria, AustraliaDepartment of Nephrology, Northern Health, Victoria, Australia Correspondence: Ashani Lecamwasam, 145 Studley Rd, Heidelberg, VIC 3084, Australia. Email: a.lecamwasam@unimelb.edu.au. https://orcid.org/0000-0002-1960-2242 Search for other works by this author on: Oxford Academic Google Scholar Elif I Ekinci Elif I Ekinci Department of Endocrinology, Austin Health, Victoria, AustraliaDepartment of Medicine, University of Melbourne, Victoria, AustraliaAustralian Centre for Accelerating Diabetes Innovations (ACADI), The University ofMelbourne, Australia https://orcid.org/0000-0003-2372-395X Search for other works by this author on: Oxford Academic Google Scholar The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 10, October 2022, Pages e4246–e4247, https://doi.org/10.1210/clinem/dgac329 Published: 08 June 2022 Article history Editorial decision: 18 May 2022 Received: 18 May 2022 Published: 08 June 2022 Corrected and typeset: 15 June 2022